Summary. People with familial history of disease often consult with genetic counselors about their chance of carrying mutations that increase disease risk.
Introduction
People who are concerned that their family has a high prevalence of disease may seek genetic counselling to assess their risk of carrying inherited genetic mutations that cause the disease (Croyle and Lerman, 1999) . To aid such people (referred to as consultands), genetic counselors employ statistical models that predict whether the consultand carries deleterious mutations by using the consultand's reported family history of disease. For syndromes whose onset occurs over a lifetime (as is common in cancer), family history is the age at which each family member developed disease, or that member's current age or age at death. Models that combine family history information with knowledge of each gene's mode of Mendelian transmission, penetrance (probability of disease given genotype), and prevalence are called Mendelian models. These models determine the probability that the consultand is a mutation carrier via Bayes's rule and Mendel's laws (Murphy and Mutalik, 1969) . The consultand's carrier probability is a crucial component in the consultand's decision to take a genetic test (if a test exists), to undergo frequent disease screening, or to consider prophylactic options. For the BreastOvarian Cancer Syndrome (Claus et al., 1996) , the popular Mendelian model BRCAPRO estimates the probability that a consultand carries a deleterious mutation in the BRCA1 and BRCA2 genes, based on family history of breast and ovarian cancer (see Berry et al., 1997 and Parmigiani et al., 1998 ). Another example is CRCAPRO, which computes the probability of carrying a mutation in the genes MLH1 and MSH2 given family history of colorectal and endometrial cancer .
However, Mendelian models rely on accurate knowledge of family history.
Consultands cannot always provide accurate information; sometimes they cannot provide the required information, or mistakenly provide inaccurate information. Error rates depend on many variables, including disease type, age-at-diagnosis, and degree of relationship to the consultand; for example, consultands report only 44% of the ovarian cancers in their second-degree (2 • ) relatives (Ziogas and Anton-Culver, 2003) .
Such errors can seriously distort the carrier probability estimate. For example, consider an Ashkenazi-Jewish consultand reporting herself as cancerfree at age 50, reporting that her mother got breast cancer at age 70, but unaware that her grandmother had ovarian cancer at age 50. Then BR-CAPRO estimates her probability of carrying a BRCA mutation as 3.5%, but her BRCAPRO probability based on correct information is 19%. This is especially important because genetic counselors often offer genetic testing to the consultand once the probability breeches 10% (Domchek et al., 2003) .
Genetic counselors working in academia or controlled studies try to con-tact other relatives to verify the given information, but relatives may be deceased or otherwise difficult to contact. Furthermore, genetic counselors not working in those settings may have limited options for verifying the given information. Thus inaccurate family history is a reality of genetic counselling, but we are unaware of any methodological contribution addressing this complex problem. This paper examines Mendelian models to determine the distortion of the carrier probability by three types of misreported family history:
1. Diagnosis incorrect, Age-at-diagnosis correct: This error results from the consultand knowing that something happened to their relative at that age, but not knowing what. In the example above, ovarian cancer diagnoses are often concealed from the family. Since ovarian cancer is often rapidly fatal, the age-at-death approximates the true age-atdiagnosis of ovarian cancer. This paper primarily concerns this error.
2. Diagnosis correct, Age-at-diagnosis incorrect: Here the consultand remembers a relative's disease diagnosis but not their age at diagnosis.
This error also happens if the model requires age-of-onset rather than age-of-diagnosis. Often, all that is known is an age range within which the relative developed disease.
3. Diagnosis incorrect, Age-at-diagnosis incorrect.
This paper shows a convenient interpretation of the Bayes Factor (BF) from Mendelian models. Defining the distortion of the estimated carrier odds caused by errors as the ratio of the BF given correct information to the BF given misreported information, we derive the distortion caused by the first type of error in each family member, both exactly and for a rare autosomaldominant mutation, for a general Mendelian model and for BRCAPRO. This distortion takes the form of a hazard ratio. Misreported diagnoses usually cause more distortion than misreported ages, so this paper focuses on this aspect. The last two types of error are considered within BRCAPRO.
Computing the Carrier Probability
Mendelian models require knowledge of which disease each relative developed and the age when it was diagnosed, or if no disease developed, the current age or age of death. For simplicity, assume that only one disease is involved in the syndrome, so c i = 0, 1 indicates disease in relative i and y i is the age of diagnosis (or current age or age at death). Let H i = (y i , c i ) and
Assume that individuals independently inherit one allele from each parent at each autosomal locus and that the alleles are either normal or mutated. Let γ i = 0, 1 indicate carrying the genotype(s) that confer(s) disease risk; for example, γ i = 1 for a dominant trait when the member carries at least 1 mutant allele, but for a recessive trait γ i = 1 implies the relative carries two mutant alleles. The absolutely continuous penetrance survivals S 0 , S 1 are the probability of surviving the disease up to some age, given γ i = 0, 1 respectively; similarly for the penetrance densities f 0 , f 1 and penetrance hazards h 0 , h 1 . The population prevalence of γ i = 1 is π. The aim is the consultand's carrier probability P (γ 0 = 1|H).
By Bayes rule, the odds of the consultand being a carrier is a product of the prior odds in the population and the Bayes Factor:
Since family history only affects the carrier probability through the Bayes Factor (BF), it suffices to consider the effect of errors in family history on the BF. Section 2.1 shows and interprets the BF, and later sections examine the effect of errors on the BF.
Bayes Factor for a General Family
If all relationships between the ancestors and the descendants are via the consultand, then conditioning on the consultand makes the ancestors independent of the descendants. The BF breaks into contributions from the (c)onsultand, the (a)ncestors, and the (d)escendants. Thus
For the consultand, the likelihood is
assuming independent non-informative censoring. The censoring mechanism always drops out of the likelihood and will never be referred to ). The BF is
BF c is a ratio of penetrance densities if the consultand has the disease, otherwise, it is the ratio of penetrance survivals.
Assuming that H i is independent of all other information, given that member's γ i , then contributions to the BF from family members are channeled through the first-degree (1 • ) relatives, i.e. parents and children. Thus BF a is funneled through the parents, so conditioning on their genotypes breaks the ancestors into independent contributions from mother's side ancestors, father's side ancestors and siblings' families (who contribute only through their connection to the parents). The likelihood is (2) where H f is the vector of all the father's side phenotypes, H m is the mother's side phenotypes and H s are each sibling's side phenotypes. Let A ij be each term in (2) when γ 0 = 0 and w ij = A 00 A 01 A 10 A 11 /A ij . Then , where B ij is the BF contributed by the parents if their genotypes were known:
Thus BF a is a weighted average of BFs that the parents would contribute if their genotypes were known. Since their genotypes are unknown, the BF is a weighted average of the two, with weights w ij reflecting the likelihood of the parents' possible genotype. However, if backwards transmission of γ 0 = 0 is impossible, then one of the B ij = 1/0 = ∞ and the weighted-average interpretation breaks down.
The descendants are the kids of the consultand and their families. Their likelihood contribution is
where H k are all the phenotypes within the family of kid k. Thus the BF breaks into pieces from the consultand and family. The family contributes a weighted average of the BFs from 1
• relatives if their genotypes were known. For simple families, such as consultand/mother or consultand/mother/maternal grandmother, the weights are the likelihood of the relatives' data given the consultand's carrier status and the BFs that are averaged over are the likelihoods of the mother being a carrier given the consultand's carrier status -see the Appendix, which also provides approximate BFs for a rare autosomal-dominant mutation. The rest of the paper shows the distortion of BF by the three types of errors of section 1.
Effect of Misreported Diagnosis
Under the first type of error (which assumes known age of diagnosis), the effect of misreported diagnosis on the BF can be summarized by a ratio of BFs, the numerator being the BF for the family member correctly having disease and the denominator for the family member incorrectly not having disease.
This is an underreporting error; for overreporting, the ratio is inverted.
If the consultand has underreported cancer, then the BF ratio is
the hazard ratio of the mutation vs. wildtype (since age of diagnosis is known, it is dropped as an argument). Thus errors in diagnosis are irrelevant if the diagnoses imply equivalent hazards at the age of diagnosis. Furthermore, if the hazards are proportional, then misreporting causes the same distortion at any age. Since the BF factors into contributions from the consultand and from the family, the BF ratio for the misreporting in the family is a product of (3) with the BF ratio from the family derived below. It is most useful to consider the effect of misreporting diagnosis in a single 1 • or 2 • relative.
Misreporting a 1 • relative's diagnosis
In a consultand/1
• -relative family with underreported 1 • relative's diagnosis, then the ratio of BFs is (see Appendix for derivation of the BF)
The h
(1) j are weighted averages of h 0 , h 1 . Since a ratio of weighted averages of two quantities is less than the ratio of the two quantities, then misreporting a 1 • relative distorts the BF less than the same misreport in the consultand. Furthermore, the weighting depends on the inverse of 
Equations (6) and (3) are the same except for the '1+' terms, and (6) is a linear function of the hazard ratio, which is the effect of an underreport for the consultand. The intercept and slope sum to one, and each are posterior probabilities of being a non-carrier (and carrier, respectively) given being unaffected, assuming even prior odds of being a carrier. Thus, when h 1 /h 0 = 1, then h
1 /h
(1) 0 = 1; no-distortion in the consultand is also no-distortion for the 1
• relative. The distortion caused by misreported diagnosis in 1 • relatives is less than that caused by the same misreported diagnosis in the consultand (figure 1). At early ages of diagnosis, when S 0 ≈ S 1 ≈ 1, the distortion in the BF by misreported diagnoses in 1 • relatives is half that of the same misreported diagnosis in the consultand. Furthermore, if the mutation is strongly deleterious and shifts the age of onset to earlier ages (like BRCA), then the survival ratio is small at older ages and the hazard ratio decreases at older ages, and the distortion attenuates. Thus misreported diagnoses in old enough 1 • relatives cause little distortion. Intuitively, if S 1 (y) ≈ 0, then the relative has reached an age that carriers rarely reach, thus the relative is unlikely to be a carrier. It doesn't matter what happens at age y, just reaching that age suffices.
[ Figure 1 
0 where
Again, this is a ratio of weighted averages of the hazards. Under the rare autosomal-dominant mutation approximation of (A.2), the ratios are
These ratios are of the form g(α 1 ) = (1 + α 1 (1 + A))/(1 + α 1 (1 + B)) where 
, a linear function of the BF ratio for the 1 • relative. The intercept and slope are less than 1, so we again have attenuation. Plugging in equation (6),
the BF ratio in the 2 • relative is linear in the BF ratio for the consultand (Figure 1) . Thus, since g(α 1 ) is monotone increasing, and if f 1 /f 0 > S 1 /S 0 (but small enough so the rare mutation approximation (A.2) still holds; reasonable for BRCA after age 35), then misreported diagnosis in the 2 • relative causes greater distortion if the 1 • relative is affected rather than unaffected.
But the change in the distortion with age of the 2 • relative strongly depends on the status and age of the 1 • relative, so no simple rules can be stated. Figure 2 shows the BF ratio for underreported breast cancer diagnoses in family members in the simple families for the BRCA1 carrier probability in Ashkenazi Jews. The penetrances are from Chen, Iversen, et al., 2004 . The consultand is 10 and 20 years younger than the 1 • and 2
Application to BRCAPRO
• relative respectively.
Each solid line is the exact BF ratio for the family and the dotted line is the rare mutation approximation. Underreporting the consultand leads to BF ratios of 20 at young ages and decreases to 7 at old ages (as noted in section 3, these BF ratios are the hazard ratios). Underreporting a single 1 • relative leads to BF ratios that go from 7.5 to 2.5, and the lowest two lines show the effect of underreporting a 2 • relative fixing the 1 • relative. The BF ratios for each error are closely log-linear in age because the hazard ratios are closely log-linear in age. The approximations tend to slightly overestimate the effect of underreporting. The approximation tends to be rougher if the penetrance density ratio is high (see Appendix), as it is at younger ages. Also, the requirements of the approximation for 2 • relatives are more stringent than for 1
• relatives (see Appendix), so the quality of the approximation depends on the family. However, the approximation does correctly predict that BF ratio for 2
• relatives with affected 1 • relatives is higher than for unaffected 1
• relatives. For a rare mutation like BRCA, an underreporting BF ratio of just two will halve the carrier probability, so these errors can have big impact.
[ Figure 2 about here.]
Effect of Errors in Age of Diagnosis
Errors in age of diagnosis can be summarized by ratios of BFs, the numerator with the BF given the true age and denominator the BF with the incorrectly reported age. Often a consultand cannot recall the exact age, but can specify a range within which the true age lies. This is like a round-off error.
Although general results are difficult to obtain, it is easy to simulate such errors in a specific model, such as BRCAPRO. For the simple families of the Appendix, the two left panels of figure 3 show the distortion in the BF caused by rounding the age of a single 1 • relative to the nearest 30 (±15 years) and 10 (±5 years) and the two right panels of figure 3 show the effect of rounding the age of a single 2 • relative to the nearest 30 and 10, assuming an affected 1
• relative with known age of diagnosis at the true age of diagnosis of the 2
• relative. Errors of ±15 years cause a maximum distortion of 70% in the BF, and a maximum 20% distortion for ±5 years. Similar computations show that the BF ratio for rounding age to the nearest 30 in unaffected relatives is no more than 1.15. Figure 4 shows the effect of simultaneous underreporting and rounding errors. Clearly, underreporting diagnosis is the more important error, but figure 3 shows that strong rounding error can cause meaningful distortion.
[ 
Discussion
The three types of misreported family history discussed in this paper can seriously distort the carrier probability estimate from Mendelian mutation prediction models. The distortion caused by misreported family history is channelled through the ratio by which it changes the true BF. The BF is the product of contributions from the consultand and the ancestors/descendants that are weighted averages of the BFs that parents and children would contribute if their genotypes were known, with weights depending on the likelihood of them carrying each genotype.
Under this special structure, the BF ratios for misdiagnosis in a relative (assuming known age of diagnosis) are ratios of weighted averages of the mutant and wildtype penetrance hazards. These ratios are generally complicated functions involving the entire family, but can be simplified in certain realistic cases. Assuming a rare autosomal-dominant mutation (like BRCA), the BF ratios in higher-degree relatives are linear in the BF ratio for the consultand and are attenuated towards one. In this case, the distortion in the BF by misreporting the diagnosis of 1 • relatives at young ages is half that of underreporting the consultand, but at old enough ages, the distortion attenuates. If the penetrance density ratio is greater than the survival ratio (like BRCA), then the effect of this error in 2 • relatives is stronger if the 1 • relative is affected. If the penetrance hazards are proportional (approximately true for BRCA1 and ovarian cancer), then the distortion caused by misdiagnosis in the consultand is the same for any age of diagnosis, although the distortion caused by this error in relatives generally depends on age.
These results were applied to BRCAPRO. The amount of distortion de-creases with age of relative, but also depends on the relationship to the consultand and outcomes in other relatives. Misreporting age of diagnosis in BRCAPRO for unaffected relatives has little effect. But the same error in affected relatives, while not as important as misreporting diagnosis, can have meaningful effects if the the error is strong enough. For a rare mutation like BRCA, an underreporting BF ratio of just two will halve the carrier probability, and figures 2 and 4 show that the distortion is often much worse.
These results can alert genetic counselors to which types of reported family history require verification, for general Mendelian models and BRCAPRO in particular. Educating genetic counselors about these results is a major challenge. The intuition developed under the rare-mutation approximation could be useful for providing general guidelines. For a specific model, an easily interpretable version of the BF ratio graphs could be a handy reference for the counselor. The next step is proposing Mendelian models that handle misreported family history by accounting for population-based misreporting rates, such as those reported by Ziogas and Anton-Culver (2003) . and the BF is
The BF breaks into a product of the BF from the consultand (BF c ) and a contribution from the 1
• relative that is funneled through
Furthermore, the backwards transmission probability ratios p 1i /p 0i = P (γ 1 = i|γ 0 = 1)/P (γ 1 = i|γ 0 = 0) are the Bayes Factors in favor of the consultand being a carrier, if the 1 • relative's carrier status is known. Since it is unknown, the BF is a weighted average of the two, with weights M ij reflecting how likely the 1 • relative is a carrier. Assuming a rare autosomal-dominant mutation, the BF is approximately
assuming π is rare enough so that πf 1 /f 0 ≈ πS 1 /S 0 ≈ 0.
For a consultand/1 • relative/2 • relative family (where the 2 • relative is directly related to the 1 • relative, i.e. mother and maternal grandmother), using the usual conditional assumptions, the likelihood is
P (H 1 |γ 1 )P (H 2 |γ 2 )P (γ 2 |γ 1 )P (γ 1 |γ 0 ), and the BF is • and 2
• relatives as a function of the BF ratio in the consultand (which is the hazard ratio) Figure 2 . Distortion of the Bayes Factor for Ashkenazi Jewish BRCA1 carrier probability from BRCAPRO by underreporting breast cancer diagnoses in the consultand, 1 • , and 2
• relatives (for consultand 10,20 years younger than 1
• ,2
• relatives respectively). Solid line is the exact BF ratio, dashed line is the BF ratio based on the rare mutation approximation. Figure 3 . Distortion of the Bayes Factor for Ashkenazi-Jewish BRCA1 carrier probability from BRCAPRO caused by rounding error in age of diagnosis for affected 1 • , 2 • relatives. Rounding is to nearest 30 (±15 years) or nearest 10 (±5 years). The 2
• relatives have the 1 • relative known affected at the true age of diagnosis of the 2
• relative. • relatives on the Bayes Factor for AshkenaziJewish BRCA1 carrier probability from BRCAPRO. The top two lines are for underreporting the 1
• relative, and bottom two for the 2 • relative. For the 2
• relatives, they have 1 • relative known affected at the true age of diagnosis of the 2
• relative. Solid line is rounding to nearest 10, dashed line is nearest 30.
